Provethas joined forces with Sentrx  Animal Care as the exclusive distributor representing  the particular patented crosslinked Hyaluronic Acid BioHAnce brand of products nationwide.

The following Sentrx ophthalmology products are now available through Provet to all authorized veterinary customers:   Ocunovis BioHAnce Gel Eye Drops,   Oculenis BioHAnce Ocular Barrier Gel. This was effective September 28, 2022, according to a company release. ¹

All Sentrx products consist of patented, clinically proven  BioHAnce  technology. This partnership enables Australian veterinarians to prescribe the first and only formulation with cross-linked hyaluronic acid (HA). The cross-linking of BioHAnce offers the longest lasting ocular lubrication on the market, that supports consistency of the tear film plus improves typically the eye’s ability to maintain hydration.

“The benefits of topical hyaluronic acid (HA) use are well known within the global vet ophthalmology community, so it is exciting to be launching this first HA-based eye drops for companion animals in  Australia”, expressed  Brian Segebrecht, Chief Executive Officer associated with Sentrx, in the release. ¹

“However, doing so with BioHAnce is even more exciting.   The trademarked cross-linking regarding BioHAnce™ just elevates often the benefits involving HA, in addition to Sentrx continues to generate more and even more fascinating clinical data supporting these benefits. ”

Reference

Sentrx Animal Treatment Partners along with Provet in order to Launch First Crosslinked Hyaluronic Acid Vision Lubricant with regard to Dogs together with Cats in Australia. News release. Sentrx Animal Care. September 29, 2022. Accessed Sept 30, 2022. https://www.prnewswire.com/news-releases/sentrx-animal-care-partners-with-provet-to-launch-first-crosslinked-hyaluronic-acid-eye-lubricant-for-dogs-and-cats-in-australia-301637076.html